Indication

Paralytic ileus prevention

Paralytic ileus prevention refers to clinical and pharmacological strategies designed to mitigate the temporary disruption or cessation of gastrointestinal motility in the absence of a mechanical obstruction. Read more about Paralytic ileus prevention

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Paralytic ileus prevention therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Paralytic ileus prevention preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Paralytic ileus prevention.

Paralytic ileus prevention refers to clinical and pharmacological strategies designed to mitigate the temporary disruption or cessation of gastrointestinal motility in the absence of a mechanical obstruction.

This functional impairment predominantly affects surgical and hospitalized populations, arising most frequently following abdominal or pelvic operations, severe systemic illness, or opioid administration.

Pathophysiologically, it results from surgical manipulation, local neurogenic reflex hyperactivity, activation of local inflammatory cascades within the muscularis externa, and disruption of enteric neurotransmission.

Prophylaxis targets these mechanisms to prevent hallmark manifestations such as marked abdominal distension, nausea, vomiting, delayed passage of flatus or stool, and intolerance to enteral nutrition.

Personalize your experience

Follow Paralytic ileus prevention and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it